11-10-2015 19:58 via articlefeeds.nasdaq.com

Why Juno Therapeutics Shares Jumped 12% In September

Juno Therapeutics is developing next generation cancer therapies that use a patient's own immune system to find and destroy cancer cells.Although the company doesn't have any drugs currently on the market,
Read more »